Our company is an R&D-driven organization that develops ophthalmic diagnostic devices based on the world’s first goblet cell imaging technology, originally developed by a leading university research team in Korea. Leveraging AI-powered image analysis, we are building an integrated diagnostic platform capable of detecting not only ocular diseases such as dry eye but also a wide range of systemic conditions.